All Stories

  1. Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial

    Article • Journal of Bone and Mineral Research, May 2026, Oxford University Press (OUP)

    Peter Schwarz

  2. Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial

    Article • Journal of Bone and Mineral Research, February 2026, Oxford University Press (OUP)

    Peter Schwarz

  3. Body composition changes in women with early breast cancer after adjuvant treatment: a systematic review

    Article • Acta Oncologica, December 2025, Acta Dermato-Venereologica

    Peter Schwarz

  4. Levels of plasma 25-hydroxy vitamin D and risk of developing type 2 diabetes in a large Danish primary health care population

    Article • Acta Diabetologica, September 2024, Springer Science + Business Media

    Peter Schwarz

  5. Diurnal fluctuations in biochemical parameters related to calcium homeostasis – the Bispebjerg study of diurnal variations

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, July 2024, Taylor & Francis

    Peter Schwarz

  6. Development of an App for Symptom Management in Women With Breast Cancer Receiving Maintenance Aromatase Inhibitors: Protocol for a Mixed Methods Feasibility Study

    Article • JMIR Research Protocols, February 2024, JMIR Publications Inc.

    Peter Schwarz

  7. Measurement of plasma total calcium before plasma free ionized calcium – a possibility with affordable pitfalls

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, February 2024, Taylor & Francis

    Peter Schwarz

  8. Psychological impairment in inflammatory bowel diseases: the key role of coping and defense mechanisms

    Article • Research in Psychotherapy Psychopathology Process and Outcome, January 2024, PAGEPress Publications

    Peter Schwarz

  9. Single zoledronic acid infusion as a cause of acute kidney impairment requiring dialysis in two patients with osteoporosis

    Article • Archives of Endocrinology and Metabolism, January 2024, Archives of Endocrinology and Metabolism

    Djordje Marina, Peter Schwarz

  10. Development of an App for Symptom Management in Women With Breast Cancer Receiving Maintenance Aromatase Inhibitors: Protocol for a Mixed Methods Feasibility Study (Preprint)

    Article • June 2023, JMIR Publications Inc.

    Peter Schwarz

  11. Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer

    Article • December 2022, Cold Spring Harbor Laboratory Press

    Djordje Marina, Peter Schwarz

  12. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report

    Article • Journal of Medical Case Reports, September 2021, Springer Science + Business Media

    Peter Schwarz

  13. Weight Change in Post-Menopausal Women with Breast Cancer during Chemotherapy—Perspectives on Nutrition, Activity and Bone Metabolism: An Interim Analysis of a 5-Year Prospective Cohort

    Article • Nutrients, August 2021, MDPI AG

    Peter Schwarz

  14. Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up

    Article • International Journal of Environmental Research and Public Health, July 2021, MDPI AG

    Peter Schwarz

  15. RANKL regulates male reproductive function

    Article • Nature Communications, April 2021, Springer Science + Business Media

    Peter Schwarz

  16. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial

    Article • Journal of Bone and Mineral Research, December 2020, Oxford University Press (OUP)

    Peter Schwarz

  17. Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer

    Article • PLOS One, March 2020, PLOS

    Peter Schwarz

  18. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    Article • The Lancet Diabetes & Endocrinology, December 2019, Elsevier

    Peter Schwarz

  19. Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark

    Article • International Journal of Cancer, January 2019, Wiley

    Peter Schwarz

  20. Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism-A systematic review

    Article • Cancer Medicine, December 2018, Wiley

    Peter Schwarz

  21. Chronic Non-bacterial Osteomyelitis: A Review

    Article • Calcified Tissue International, November 2018, Springer Science + Business Media

    Peter Schwarz

  22. The association of celiac disease and allergic disease in a general adult population

    Article • United European Gastroenterology Journal, November 2018, SAGE Publications

    Peter Schwarz

  23. FRAX Calculated without BMD Resulting in a Higher Fracture Risk Than That Calculated with BMD

    Article • Journal of Osteoporosis, October 2018, Hindawi Publishing Corporation

    Peter Schwarz, Rizky Suganda Prawiradilaga

  24. Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report

    Article • Journal of Medical Case Reports, September 2018, Springer Science + Business Media

    Bo Abrahamsen, Peter Schwarz

  25. Identification and Functional Characterization of a Novel Mutation in the Human Calcium-Sensing Receptor That Co-Segregates With Autosomal-Dominant Hypocalcemia

    Article • Frontiers in Endocrinology, April 2018, Frontiers

    Peter Schwarz

  26. Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation

    Article • Physiological Reports, April 2018, Wiley

    Peter Schwarz

  27. The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis

    Article • Bone Reports, December 2017, Elsevier

    Peter Schwarz

  28. P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients

    Article • Frontiers in Pharmacology, November 2017, Frontiers

    Peter Schwarz, Director of the stroke unit, DMSci, clinical research associate professor Helle K. Iversen

  29. Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors

    Article • European Geriatric Medicine, November 2017, Elsevier

    Bo Abrahamsen, Peter Schwarz

  30. Erratum to: determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors

    Article • BMC Public Health, July 2017, Springer Science + Business Media

    Peter Schwarz

  31. P2X7Rs are involved in cell death, growth and cellular signaling in primary human osteoblasts

    Article • Bone, February 2017, Elsevier

    Peter Schwarz

  32. Letter to the Editor Response: The J-shaped 25-hydroxyvitamin D concentration/CVD-mortality relation is an artifact caused by lack of correction due to age, by Steen Ahrenkiel

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2016, Endocrine Society

    Peter Schwarz

  33. Determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors

    Article • BMC Public Health, May 2016, Springer Science + Business Media

    Peter Schwarz

  34. Physical exercise associated with improved BMD independently of sex and vitamin D levels in young adults

    Article • European Journal of Applied Physiology and Occupational Physiology, May 2016, Springer Science + Business Media

    Peter Schwarz

  35. Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion

    Article • Calcified Tissue International, April 2016, Springer Science + Business Media

    Bo Abrahamsen, Peter Schwarz

  36. Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis

    Article • Osteoporosis International, February 2016, Springer Science + Business Media

    Peter Schwarz

  37. Fine-tuned ATP signals are acute mediators in osteocyte mechanotransduction

    Article • Cellular Signalling, December 2015, Elsevier

    Peter Schwarz

  38. Perceived age is associated with bone status in women aged 25–93 years

    Article • AGE, October 2015, Springer Science + Business Media

    Peter Schwarz

  39. Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study

    Article • Archives of Osteoporosis, October 2015, Springer Science + Business Media

    Bo Abrahamsen, Peter Schwarz

  40. The Influence of Clinical Experience and Photographic Presentation on Age Assessment of Women

    Article • Gerontology, September 2015, Karger Publishers

    Peter Schwarz

  41. Serum 25-hydroxyvitamin D and self-reported mental health status in adult Danes

    Article • European Journal of Clinical Nutrition, August 2015, Springer Science + Business Media

    Peter Schwarz

  42. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2015, Endocrine Society

    Peter Schwarz

  43. Response to the letter by Grant

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2015, Endocrine Society

    Peter Schwarz

  44. Association between leukocyte telomere length and bone mineral density in women 25–93years of age

    Article • Experimental Gerontology, June 2015, Elsevier

    Peter Schwarz

  45. Screening for celiac disease in Danish adults

    Article • Scandinavian Journal of Gastroenterology, February 2015, Taylor & Francis

    Peter Schwarz

  46. The PRIMARA study to review cinacalcet use in patients with primary hyperparathyroidism

    Article • European Journal of Endocrinology, December 2014, Bioscientifica

    Peter Schwarz

  47. Muscle strength, power and cardiorespiratory fitness are associated with bone mineral density in men aged 31–60 years

    Article • Scandinavian Journal of Public Health, September 2014, SAGE Publications

    Peter Schwarz

  48. A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures

    Article • BoneKEy Reports, September 2014, Portico

    Bo Abrahamsen, Peter Schwarz

  49. Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients

    Article • Osteoporosis International, August 2014, Springer Science + Business Media

    Bo Abrahamsen, Peter Schwarz

  50. Genetic variants in theP2RX7gene are associated with risk of multiple myeloma

    Article • European Journal Of Haematology, May 2014, Wiley

    Professor Ulla B Vogel, Peter Schwarz

  51. Non-infectious osteomyelitis of the mandible in a young woman: a case report

    Article • Journal of Medical Case Reports, February 2014, Springer Science + Business Media

    Peter Schwarz

  52. Status of drug development for the prevention and treatment of osteoporosis

    Article • Expert Opinion on Drug Discovery, February 2014, Informa Healthcare

    Bo Abrahamsen, Peter Schwarz

  53. The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?

    Article • The Scientific World JOURNAL, January 2014, Hindawi Publishing Corporation

    Peter Schwarz

  54. UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes

    Article • Purinergic Signalling, December 2013, Springer Science + Business Media

    Peter Schwarz

  55. The effect of PTH(1-34) on fracture healing during different loading conditions

    Article • Journal of Bone and Mineral Research, September 2013, Wiley

    Peter Schwarz

  56. A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis

    Article • PLOS One, July 2013, PLOS

    Peter Schwarz

  57. Purinergic Signaling in Bone

    Article • Journal of Osteoporosis, January 2013, Hindawi Publishing Corporation

    Professor Elena Adinolfi, Peter Schwarz

  58. Low levels of vitamin D are associated with increased mortality in patients attending a university hospital in Denmark

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, November 2012, Taylor & Francis

    Peter Schwarz

  59. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status

    Article • Endocrine, November 2012, Springer Science + Business Media

    Peter Schwarz

  60. Clopidogrel (Plavix), a P2Y12receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo

    Article • Journal of Bone and Mineral Research, October 2012, Wiley

    Peter Schwarz

  61. Gastrointestinal Events with Clopidogrel: A Nationwide Population-Based Cohort Study

    Article • Journal of General Internal Medicine, September 2012, Springer Science + Business Media

    Peter Schwarz

  62. Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac disease

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, September 2012, Taylor & Francis

    Peter Schwarz

  63. Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture

    Article • International Journal of Cardiology, September 2012, Elsevier

    Peter Schwarz

  64. A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2012, Endocrine Society

    Peter Schwarz

  65. Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients

    Article • Osteoporosis International, July 2012, Springer Science + Business Media

    Peter Schwarz

  66. Association of P2Y2 receptor SNPs with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients

    Article • Purinergic Signalling, July 2012, Springer Science + Business Media

    Peter Schwarz

  67. Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice

    Article • Injury, July 2012, Elsevier

    Peter Schwarz

  68. Elevated liver enzymes, anaemia and osteopaenia in a young woman

    Article • BMJ Case Reports, June 2012, BMJ

    Peter Schwarz

  69. Paget's disease of the bone after treatment with Denosumab: A case report

    Article • Bone, May 2012, Elsevier

    Peter Schwarz

  70. Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study

    Article • Journal of Internal Medicine, March 2012, Wiley

    Peter Schwarz

  71. Determinants of vitamin D status in a general population of Danish adults

    Article • Bone, March 2012, Elsevier

    Peter Schwarz

  72. Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures

    Article • European Journal of Human Genetics, January 2012, Springer Science + Business Media

    Peter Schwarz

  73. Effects of Increasing Age, Dosage, and Duration of PTH Treatment on BMD Increase—A Meta-analysis

    Article • Calcified Tissue International, January 2012, Springer Science + Business Media

    Peter Schwarz

  74. Association between P2X7 Receptor Polymorphisms and Bone Status in Mice

    Article • Journal of Osteoporosis, January 2012, Hindawi Publishing Corporation

    Peter Schwarz

  75. Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice

    Article • Journal of Osteoporosis, January 2012, Hindawi Publishing Corporation

    Peter Schwarz

  76. Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series

    Article • Journal of Medical Case Reports, December 2011, Springer Science + Business Media

    Peter Schwarz

  77. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, November 2011, Taylor & Francis

    Peter Schwarz

  78. Effects of Anti-osteoporosis Medications on Fracture Healing

    Article • Current Osteoporosis Reports, June 2011, Springer Science + Business Media

    Peter Schwarz

  79. Role of purinergic receptor polymorphisms in human bone

    Article • Frontiers in Bioscience, January 2011, Frontiers in Bioscience

    Peter Schwarz

  80. The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men

    Article • Journal of Osteoporosis, January 2011, Hindawi Publishing Corporation

    Peter Schwarz

  81. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution

    Article • Nature Genetics, October 2010, Springer Science + Business Media

    Dr Massimo Mangino, Peter Schwarz, Dr Ulla Sovio

  82. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

    Article • Nature Genetics, October 2010, Springer Science + Business Media

    Dr Massimo Mangino, Peter Schwarz, Dr Ulla Sovio

  83. Effect of a program of multifactorial fall prevention on health-related quality of life, functional ability, fear of falling and psychological well-being. A randomized controlled trial

    Article • Aging Clinical and Experimental Research, June 2010, Springer Science + Business Media

    Peter Schwarz

  84. Parathyroid Hormone and Bone Healing

    Article • Calcified Tissue International, April 2010, Springer Science + Business Media

    Peter Schwarz

  85. Amylin(1–8) is Devoid of Anabolic Activity in Bone

    Article • Calcified Tissue International, February 2010, Springer Science + Business Media

    Peter Schwarz

  86. Glucocorticoid Induced Osteopenia in Cancellous Bone of Sheep

    Article • Spine, February 2010, Wolters Kluwer Health

    Peter Schwarz

  87. Baseline and Follow-Up Characteristics of Participants and Nonparticipants in a Randomized Clinical Trial of Multifactorial Fall Prevention in Denmark

    Article • Journal of the American Geriatrics Society, October 2009, Wiley

    Peter Schwarz

  88. An Outpatient Multifactorial Falls Prevention Intervention Does Not Reduce Falls in High-Risk Elderly Danes

    Article • Journal of the American Geriatrics Society, June 2009, Wiley

    Peter Schwarz

  89. Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass, strength, and bone formation in postmenopausal women

    Article • Journal of Applied Physiology, July 2008, American Physiological Society

    Peter Schwarz

  90. Osteoporosis in chronic obstructive pulmonary disease patients

    Article • Current Opinion in Pulmonary Medicine, March 2008, Wolters Kluwer Health

    Peter Schwarz

  91. Primary and Secondary Prophylaxis to the Use of Inhaled Glucocorticoid in Primary Health Care

    Article • Journal of Asthma, January 2008, Taylor & Francis

    Peter Schwarz

  92. Mechanical Muscle Function, Morphology, and Fiber Type in Lifelong Trained Elderly

    Article • Medicine & Science in Sports & Exercise, November 2007, Wolters Kluwer Health

    Peter Schwarz

  93. Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis

    Article • Osteoporosis International, August 2007, Springer Science + Business Media

    Peter Schwarz

  94. Tendon collagen synthesis at rest and after exercise in women

    Article • Journal of Applied Physiology, February 2007, American Physiological Society

    Peter Schwarz, Professor Mette Hansen

  95. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease—A cross sectional study

    Article • Respiratory Medicine, January 2007, Elsevier

    Peter Schwarz

  96. Management of risk of glucocorticoid-induced osteoporosis due to systemic administration in general practice in Denmark

    Article • European Journal of General Practice, January 2007, Taylor & Francis

    Peter Schwarz

  97. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk – a meta-analysis

    Article • Osteoporosis International, September 2006, Springer Science + Business Media

    Peter Schwarz

  98. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men—results from the Odense Androgen Study

    Article • Bone, February 2006, Elsevier

    Bo Abrahamsen, Peter Schwarz

  99. No effect of menstrual cycle on myofibrillar and connective tissue protein synthesis in contracting skeletal muscle

    Article • AJP Endocrinology and Metabolism, January 2006, American Physiological Society

    Peter Schwarz, Professor Mette Hansen

  100. Calcium-Sensing Receptor Induces Proliferation through p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase But Not Extracellularly Regulated Kinase in a Model of Humoral Hypercalcemia of Malignancy

    Article • Endocrinology, March 2004, Endocrine Society

    Peter Schwarz

  101. Editorial

    Article • Scandinavian Journal of Medicine and Science in Sports, February 2004, Wiley

    Peter Schwarz

  102. Calcium-Sensing Receptor Induces Messenger Ribonucleic Acid of Human Securin, Pituitary Tumor Transforming Gene, in Rat Testicular Cancer

    Article • Endocrinology, December 2003, Endocrine Society

    Peter Schwarz

  103. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells

    Article • AJP Endocrinology and Metabolism, August 2003, American Physiological Society

    Peter Schwarz

  104. The calcium-sensing receptor in human disease

    Article • Frontiers in Bioscience, January 2003, Frontiers in Bioscience

    Peter Schwarz

  105. Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal women

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, July 2001, Taylor & Francis

    Peter Schwarz

  106. Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2001, Taylor & Francis

    Peter Schwarz

  107. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2000, Taylor & Francis

    Peter Schwarz

  108. The Vitamin D Receptor (VDR) Start Codon Polymorphism in Primary Hyperparathyroidism and Parathyroid VDR Messenger Ribonucleic Acid Levels1

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1999, Endocrine Society

    Peter Schwarz

  109. Evidence for a role of intracellular stored parathyroid hormone in producing hysteresis of the PTH–calcium relationship in normal humans

    Article • Clinical Endocrinology, June 1998, Wiley

    Peter Schwarz

  110. Effect of nasal salmon calcitonin on posttraumatic osteopenia following ankle fracture: A randomized double-blind placebo-controlled study in 24 patients

    Article • Acta Orthopaedica Scandinavica, January 1998, Taylor & Francis

    Peter Schwarz

  111. A mathematical/physiological model of parathyroid hormone secretion in response to blood-ionized calcium loweringin vivo

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1997, Taylor & Francis

    Peter Schwarz

  112. Parathyroid hormone secretion in chronic renal failure

    Article • Kidney International, November 1996, Elsevier

    Peter Schwarz

  113. Inter-relations between the calcium set-points of Parfitt and Brown in primary hyperparathyroidism: a sequential citrate and calcium clamp study

    Article • European Journal of Clinical Investigation, August 1994, Wiley

    Peter Schwarz

  114. Cica-clamp technique: a method for quantifying parathyroid hormone secretion: a sequential citrate and calcium clamp study

    Article • European Journal of Clinical Investigation, September 1993, Wiley

    Peter Schwarz

  115. Changing incidence and residual lifetime risk of common osteoporosis-related fractures

    Article • Osteoporosis International, May 1993, Springer Science + Business Media

    Peter Schwarz

  116. Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation

    Article • Osteoporosis International, May 1993, Springer Science + Business Media

    Peter Schwarz

  117. Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study

    Article • Clinical Endocrinology, October 1992, Wiley

    Peter Schwarz

  118. Induced hypocalcaemia and intact PTH responsiveness in patients with primary hyperparathyroidism, primary hypoparathyroidism and normal man

    Article • Bone and Mineral, April 1992, Elsevier

    Peter Schwarz

  119. Calcium clamp technique: Suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1992, Taylor & Francis

    Peter Schwarz

  120. Induced hypocalcaemia controlled by a citrate clamp technique, and the intact parathyroid hormone response obtained

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1990, Taylor & Francis

    Peter Schwarz